Radiopharmaceuticals
Ended Definitive Contract Awarded Last action
- Contract number
- 36C25721C0005
- Awardee
-
Panhandle Nuclear RX, LTD. UEI FFB2JPB52GP9
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $430,412
Award facts
- Opportunity
-
- AMA Radiopharmaceuticals Solicitation · 36C25720Q1301 · Posted Oct 22, 2020
- 6505--Amarillo VA Healthcare System Radiopharmaceuticals Award Notice · Posted Jan 5, 2021
- Contract value 45% obligated
-
- $430,412.61 Current, with exercised options
- $963,779.11 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Amarillo, TX 79106, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$1 | |
| Supplemental Agreement for work within scope | -$64,187 | |
| Supplemental Agreement for work within scope | -$38,768 | |
| Exercise an Option | $266,684 | |
| Original award | $266,684 |
About this award
This is a $963,779.11 firm fixed-price contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Panhandle Nuclear RX, LTD., a for-profit small business based in Amarillo, Texas. The contract is for the provision of radiopharmaceuticals to support diagnostic imaging services within the VA's Veterans Integrated Service Network 17 (VISN 17). The contract has a period of performance from January 4, 2021 through January 3, 2023 and was awarded under a total small business set-aside. This contract is part of a larger indefinite delivery vehicle (IDV), contract number 36C25723D0007, with a $615,206 ceiling value, also awarded to Panhandle Nuclear RX, LTD. by VHA VISN 17. The IDV has a period of performance from January 4, 2023 through January 3, 2025, and delivery orders have been issued against it for $307,603 on January 3, 2024 and $307,603 on January 4, 2023. These contracts demonstrate Panhandle Nuclear RX's role as a key supplier of radiopharmaceuticals to support diagnostic imaging for veterans within the VHA's VISN 17 healthcare network.
Quick answers
Who was awarded contract 36C25721C0005?
36C25721C0005 was awarded to Panhandle Nuclear RX, LTD. by Veterans Integrated Service Network 17 (Veterans Health Administration) on January 4, 2021.
How much is contract 36C25721C0005 worth?
The government has obligated $430,412 on 36C25721C0005. Its current value, with exercised options, is $430,413. Its potential value, with all options, is $963,779.
Was contract 36C25721C0005 competed?
The extent of competition for 36C25721C0005 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award